Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A3 | Q01959 | 3/20 | 0.43 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.43 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.41 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16409252 | 0.86 | SMN1; SMN2 (0.45) | MEN1KMT2AALDH1A1ATMSMN1; SMN2 | |
| SCHEMBL17782313 | 0.85 | MEN1 (0.42) | MEN1KMT2AALDH1A1ATMSMN1; SMN2 | |
| SCHEMBL17782315 | 0.85 | MEN1 (0.42) | MEN1KMT2AALDH1A1ATMSMN1; SMN2 | |
| SCHEMBL31480229 | 0.84 | ALDH1A1 (0.42) | SLC6A3SLC6A2SLC6A4MEN1KMT2A | |
| SCHEMBL21491473 | 0.83 | ALDH1A1 (0.39) | SLC6A3SLC6A2SLC6A4MEN1KMT2A | |
| SCHEMBL4150927 | 0.82 | MEN1 (0.47) | SLC6A3SLC6A2SLC6A4MEN1KMT2A | |
| SCHEMBL31480424 | 0.81 | YAP1 (0.44) | MEN1KMT2AALDH1A1ATMSMN1; SMN2 | |
| SCHEMBL2323853 | 0.81 | SLC6A2 (0.51) | SLC6A3SLC6A2SLC6A4MEN1KMT2A | |
| SCHEMBL31480101 | 0.81 | HPGD (0.56) | SLC6A3MEN1KMT2AALDH1A1SMN1; SMN2 | |
| SCHEMBL31480357 | 0.81 | KDM4E (0.51) | MEN1KMT2AALDH1A1L3MBTL1ATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025054361-A1 | COMPLEMENT INHIBITION | APELLIS PHARMACEUTICALS, INC. (US) | 2025-03-13 | — | — | WO | disclosed |